Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3171441 | 0.92 | ALDH1A1 (0.52) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL29459210 | 0.90 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL40372 | 0.90 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| Lithium SCHEMBL6552341 | 0.88 | ALDH1A1 (0.44) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL6552336 | 0.88 | ALDH1A1 (0.44) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| Hydrochloric Acid SCHEMBL28338025 | 0.86 | ALDH1A1 (0.42) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL28556632 | 0.83 | KIF11 (0.42) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL28338024 | 0.82 | ALDH1A1 (0.40) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL31265561 | 0.82 | ALDH1A1 (0.54) | ALDH1A1NPC1RAB9AMAPTHPGD | |
| SCHEMBL28346187 | 0.82 | ALDH1A1 (0.64) | ALDH1A1NPC1RAB9AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019154300-A1 | ENCAPSULATION ADHESIVE FILM FOR SOLAR CELL, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州赛伍应用技术股份有限公司 | 2019-08-15 | — | — | WO | claimed |
| WO-2026106216-A1 | POLYETHYLENE RESIN COMPOSITION HAVING EXCELLENT STRETCHING PROCESSABILITY | 주식회사 엘지화학 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026106217-A1 | POLYETHYLENE RESIN COMPOSITION HAVING EXCELLENT STRETCHING PROCESSABILITY | 주식회사 엘지화학 | 2026-05-21 | — | — | WO | disclosed |
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4714987-A1 | HYBRIDE SUPPORTED METALLOCENE CATALYST AND METHOD FOR PREPARING POLYETHYLENE COPOLYMER USING SAME | LG Chem, Ltd. (KR) | 2026-03-25 | — | — | EP | disclosed |
| EP-4707311-A1 | POLYETHYLENE COPOLYMER AND BIAXIALLY STRETCHED FILM COMPRISING SAME | LG CHEM, LTD. (KR) | 2026-03-11 | — | — | EP | disclosed |
| US-20210079156-A1 | TWO COMPONENT MASS POLYMERIZABLE COMPOSITIONS CONTAINING POLYCYCLOOLEFIN MONOMERS AND ORGANORUTHENIUM CARBIDE PRECATALYST | PROMERUS, LLC (US) | 2021-03-18 | — | — | US | disclosed |
| WO-2019154300-A1 | ENCAPSULATION ADHESIVE FILM FOR SOLAR CELL, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州赛伍应用技术股份有限公司 | 2019-08-15 | — | — | WO | disclosed |
| WO-2019148538-A1 | MODIFIED EPOXY ACRYLATE AND SOLDER MASK COMPRISING SAME | 江南大学 | 2019-08-08 | — | — | WO | disclosed |
| CN-109563012-A | Conversion method of butenes and purification method of monofluorobutane | 日本瑞翁株式会社 | 2019-04-02 | — | — | CN | disclosed |
| US-5436305-A | Preparing polymer catalysts by reaction of alkali metal alkyl and fluorenyl in solvent | PHILLIPS PETROLEUM COMPANY (US) | 1995-07-25 | — | — | US | disclosed |
| US-5420320-A | Method for preparing cyclopentadienyl-type ligands and metallocene compounds | PHILLIPS PETROLEUM COMPANY (US) | 1995-05-30 | — | — | US | disclosed |
| US-5406013-A | Cyclopentadiene type compounds and method for making | PHILLIPS PETROLEUM COMPANY (US) | 1995-04-11 | — | — | US | disclosed |
| US-5393911-A | Cyclopentadiene type compounds and method for making | PHILLIPS PETROLEUM COMPANY (US) | 1995-02-28 | — | — | US | disclosed |
| US-5210352-A | Fluorene compounds | PHILLIPS PETROLEUM COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5191132-A | CYCLOPENTADIENE TYPE COMPOUNDS AND METHOD FOR MAKING | PHILLIPS PETROLEUM COMPANY (US) | 1993-03-02 | — | — | US | disclosed |
| EP-0524624-A2 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM COMPANY (US) | 1993-01-27 | — | — | EP | disclosed |
| EP-0512554-A2 | Cyclopetadiene type compounds and method for making | PHILLIPS PETROLEUM COMPANY (US) | 1992-11-11 | — | — | EP | disclosed |
| US-4997737-A | Contain sulfonyl group | EASTMAN KODAK COMPANY (US) | 1991-03-05 | — | — | US | disclosed |
| US-4948911-A | ELECTRON-TRANSPORT AGENTS | EASTMAN KODAK COMPANY (US) | 1990-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | DYRK1B, DYRK2, DYRK4 | ALDH1A1 2367/4885NPC1 2930/4885RAB9A 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.